Bronstein, Gewirtz & Grossman, LLC Encourages Syndax Pharmaceuticals, Inc. (SNDX) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / October 20, 2026 /Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Syndax Pharmaceuticals, Inc. ("Syndax" or "the Company") (NASDAQ:SNDX). Investors who purchased Syndax securities are encouraged to obtain additional information and assist the investigation by visiting the firm 's site: bgandg.com/cases/syndax-pharmaceuticals-inc-sndx-investigation.
Syndax Investigation Details
On October 12, 2026, Syndax Pharmaceuticals announced that its Phase 2 MAXPIRe clinical trial evaluating axatilimab failed to meet its primary endpoint. Following this news, Syndax 's stock price declined more than 15.7% on October 13, 2026.
What 's Next for Syndax Investors?
If you are aware of any facts relating to this investigation or purchased Syndax securities, you can assist this investigation by visiting the firm 's site: bgandg.com/cases/syndax-pharmaceuticals-inc-sndx-investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Syndax Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys ' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Syndax Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | info@bgandg.com
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE:Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
